Using mobile technology to improve treatment for depression
Mobile Technology to Optimize Depression Treatment
['FUNDING_R01'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-10908307
This study is looking to improve how we treat depression by using smartphones and wearable devices to track things like sleep, activity, and social interactions, so we can find the best treatment for each person based on their own information.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded) |
| Locations | 1 site (ANN ARBOR, UNITED STATES) |
| Trial ID | NIH-10908307 on ClinicalTrials.gov |
What this research studies
This research aims to enhance depression treatment by utilizing mobile technology, such as smartphones and wearable sensors, to gather continuous and objective data on factors like sleep, physical activity, and social engagement. By analyzing this data, the study seeks to identify which treatments are most effective for individual patients, thereby personalizing care and improving recovery outcomes. The approach focuses on real-time assessment of treatment responses, addressing a significant barrier in current mental health care. Through the PROMPT study, researchers will work to match patients with the most suitable treatments based on their unique data.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing depression who are open to using mobile technology for monitoring their health.
Not a fit: Patients with severe cognitive impairments or those unable to use mobile technology may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized depression treatments, improving recovery rates for patients.
How similar studies have performed: Previous studies have shown promise in using wearable technology for health monitoring, but this approach aims to synthesize data across multiple domains, making it a novel endeavor.
Where this research is happening
ANN ARBOR, UNITED STATES
- UNIVERSITY OF MICHIGAN AT ANN ARBOR — ANN ARBOR, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SEN, SRIJAN — UNIVERSITY OF MICHIGAN AT ANN ARBOR
- Study coordinator: SEN, SRIJAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.